CCL20/MIP-3 alpha Antibody (4N8C7) Summary
Immunogen |
Full length recombinant mouse CCL20 (MIP-3a) was used as immunogen for the antibody. full length protein |
Isotype |
IgG2a Kappa |
Clonality |
Monoclonal |
Host |
Rat |
Gene |
CCL20 |
Purity |
Protein G purified |
Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
Reactivity Notes
This monoclonal antibody is specific to mouse CCL20, it will not cross-react with human CCL20.
Packaging, Storage & Formulations
Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Buffer |
0.2 ml PBS and 0.05% BSA |
Preservative |
0.05% Sodium Azide |
Concentration |
1.0 mg/ml |
Purity |
Protein G purified |
Alternate Names for CCL20/MIP-3 alpha Antibody (4N8C7)
Background
CCL20 (MIP-3a) is a small cytokine of the CC chemokine family. It acts as a chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. It is implicated in the formation and function of mucosal lymphoid tissues via chemoattraction of lymphocytes and dendritic cells towards the epithelial cells surrounding these tissues (Zhong W et al, 2010). It is expressed constitutively by keratinocytes in epidermal layers of the skin, intestinal mucosa, epithelial crypts of tonsils, and the epithelium of Payer's patches in the intestine. CCL20 triggers an adaptive immune response primarily by attracting immature dendritic cells expressing CCR6 on their surfaces to the site of inflammation, and allows the dendritic cell to take up a foreign antigen and to mature. After binding, CCR6 expression is down-regulated, causing the dendritic cell to migrate to the lymph nodes, where it binds via CCR7 and presents the antigen to CD8 T cells. Thus it forms a bridge between innate and adaptive immune response (Hoover DM et al, 2002). CCL20 plays immense role in various cancer entities, such as leukaemia, lymphoma, melanoma, hepatocellular carcinoma, prostate cancer, colorectal adenocarcinoma and lung and oral squamous cell carcinoma (He S et al, 2010). CCL20 along with its corresponding receptor CCR6, is significantly up-regulated in patients with pancreatic cancer. But inhibition of CCR6 signaling or neutralization of CCL20 or inhibition of its production and activity may be useful in preventing further progression of the disease and may be a future basic treatment strategy in the management of pancreatic cancer (Rubie C et al, 2010).
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: CyTOF-ready, Flow, IHC
Species: Mu
Applications: CyTOF-ready, Flow, ICC
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA
Species: Mu
Applications: ELISA
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
Species: Hu
Applications: BA
Species: Mu
Applications: BA, BA
Species: Mu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, PEP-ELISA, WB
Species: Mu
Applications: ELISA
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Mu
Applications: ELISA
Species: Hu
Applications: CyTOF-reported, Dual ISH-IHC, Flow, ICC, IHC, Neut
Species: Hu
Applications: BA
Species: Mu
Applications: ELISA
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
Species: Mu
Applications: WB
Publications for CCL20/MIP-3 alpha Antibody (NBP2-27143) (0)
There are no publications for CCL20/MIP-3 alpha Antibody (NBP2-27143).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for CCL20/MIP-3 alpha Antibody (NBP2-27143) (0)
There are no reviews for CCL20/MIP-3 alpha Antibody (NBP2-27143).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for CCL20/MIP-3 alpha Antibody (NBP2-27143) (0)
Secondary Antibodies
| |
Isotype Controls
|
Additional CCL20/MIP-3 alpha Products
Research Areas for CCL20/MIP-3 alpha Antibody (NBP2-27143)
Find related products by research area.
|
Blogs on CCL20/MIP-3 alpha